Pharma lags food in automation

The importation of food, despite occasional problems, doesn't raise the same level of objection that drug importation does. Could part of the reason be that the highly automated food industry remains ahead of the pharmaceutical industry in terms of efficiencies? Blog

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.